Home › Macular Degeneration › Indiana › Hammond
Macular Degeneration clinical trials in Hammond, IN
3 studies for Macular Degeneration are looking for participants at sites in and around Hammond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
RecruitingObservational study
- University Retina and Macula Associates, Oak Forest · 13 mi away
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RecruitingPhase 1
- University Retina and Macula Associates, Oak Forest · 13 mi away
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
RecruitingPhase 1/2
- University Retina and Macula Associates, Oak Forest · 13 mi away
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), is the leading cause of vision loss in older adults. Learn about the types and what might help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX12 studies
- Erie, PA9 studies
- The Woodlands, TX9 studies
- Sacramento, CA7 studies
- Carmel, IN7 studies
- Santa Monica, CA7 studies
- Hagerstown, MD7 studies
- Houston, TX7 studies
- Phoenix, AZ7 studies
- McAllen, TX7 studies
- Cleveland, OH7 studies
- Reno, NV7 studies
Other studies in Hammond
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Breast Cancer9 studies
- Heart Failure8 studies
- Ovarian Cancer5 studies
- High Blood Pressure4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colorectal Cancer4 studies
- Colon Cancer4 studies
- Blood Clots4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.